Clinical trial
Multicenter Trial for Adults With Partial Seizures
NCT00034814 · Teva Branded Pharmaceutical Products R&D, Inc., Industry · Completed
Key facts
| NCT number | NCT00034814 |
|---|---|
| Title | Multicenter Trial for Adults With Partial Seizures |
| Official title | Efficacy and Safety of Talampanel as Adjunctive Therapy in Patients With Partial Seizures: A Phase II Clinical Trial. |
| Lead sponsor | Teva Branded Pharmaceutical Products R&D, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Talampanel, Placebo |
| Enrollment | 190 |
| Start date | Jan 1, 2002 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | May 3, 2002 |
| Last update posted | Mar 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: